Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 91 entries
Sorted by: Best Match Show Resources per page
Efficacy of HCV treatment in Poland at the turn of the interferon era - the EpiTer study.

Clinical and experimental hepatology

Flisiak R, Pogorzelska J, Berak H, Horban A, Orłowska I, Simon K, Tuchendler E, Madej G, Piekarska A, Jabłkowski M, Deroń Z, Mazur W, Kaczmarczyk M, Janczewska E, Pisula A, Smykał J, Nowak K, Matukiewicz M, Halota W, Wernik J, Sikorska K, Mozer-Lisewska I, Rozpłochowski B, Garlicki A, Tomasiewicz K, Krzowska-Firych J, Baka-Ćwierz B, Kryczka W, Zarębska-Michaluk D, Olszok I, Boroń-Kaczmarska A, Sobala-Szczygieł B, Szlauer B, Korcz-Ondrzejek B, Sieklucki J, Pleśniak R, Ruszała A, Postawa-Kłosińska B, Citko J, Lachowicz-Wawrzyniak A, Musialik J, Jezierska E, Dobracki W, Dobracka B, Hałubiec J, Krygier R, Strokowska A, Chomczyk W, Witczak-Malinowska K.
PMID: 28856278
Clin Exp Hepatol. 2016 Dec;2(4):138-143. doi: 10.5114/ceh.2016.63870. Epub 2016 Nov 28.

THE AIM OF THE STUDY: Was to analyze the efficacy achieved with regimens available for chronic hepatitis C (CHC) in Poland between 2013 and 2016.MATERIAL AND METHODS: Data were collected from 29 centers and included 6786 patients with available...

Cite
Flisiak R, Pogorzelska J, Berak H, et al. Efficacy of HCV treatment in Poland at the turn of the interferon era - the EpiTer study. Clin Exp Hepatol. 2016;2(4):138-143doi: 10.5114/ceh.2016.63870.
Flisiak, R., Pogorzelska, J., Berak, H., Horban, A., Orłowska, I., Simon, K., Tuchendler, E., Madej, G., Piekarska, A., Jabłkowski, M., Deroń, Z., Mazur, W., Kaczmarczyk, M., Janczewska, E., Pisula, A., Smykał, J., Nowak, K., Matukiewicz, M., Halota, W., Wernik, J., Sikorska, K., Mozer-Lisewska, I., Rozpłochowski, B., Garlicki, A., Tomasiewicz, K., Krzowska-Firych, J., Baka-Ćwierz, B., Kryczka, W., Zarębska-Michaluk, D., Olszok, I., Boroń-Kaczmarska, A., Sobala-Szczygieł, B., Szlauer, B., Korcz-Ondrzejek, B., Sieklucki, J., Pleśniak, R., Ruszała, A., Postawa-Kłosińska, B., Citko, J., Lachowicz-Wawrzyniak, A., Musialik, J., Jezierska, E., Dobracki, W., Dobracka, B., Hałubiec, J., Krygier, R., Strokowska, A., Chomczyk, W., & Witczak-Malinowska, K. (2016). Efficacy of HCV treatment in Poland at the turn of the interferon era - the EpiTer study. Clinical and experimental hepatology, 2(4), 138-143. https://doi.org/10.5114/ceh.2016.63870
Flisiak, Robert, et al. "Efficacy of HCV treatment in Poland at the turn of the interferon era - the EpiTer study." Clinical and experimental hepatology vol. 2,4 (2016): 138-143. doi: https://doi.org/10.5114/ceh.2016.63870
Flisiak R, Pogorzelska J, Berak H, Horban A, Orłowska I, Simon K, Tuchendler E, Madej G, Piekarska A, Jabłkowski M, Deroń Z, Mazur W, Kaczmarczyk M, Janczewska E, Pisula A, Smykał J, Nowak K, Matukiewicz M, Halota W, Wernik J, Sikorska K, Mozer-Lisewska I, Rozpłochowski B, Garlicki A, Tomasiewicz K, Krzowska-Firych J, Baka-Ćwierz B, Kryczka W, Zarębska-Michaluk D, Olszok I, Boroń-Kaczmarska A, Sobala-Szczygieł B, Szlauer B, Korcz-Ondrzejek B, Sieklucki J, Pleśniak R, Ruszała A, Postawa-Kłosińska B, Citko J, Lachowicz-Wawrzyniak A, Musialik J, Jezierska E, Dobracki W, Dobracka B, Hałubiec J, Krygier R, Strokowska A, Chomczyk W, Witczak-Malinowska K. Efficacy of HCV treatment in Poland at the turn of the interferon era - the EpiTer study. Clin Exp Hepatol. 2016 Dec;2(4):138-143. doi: 10.5114/ceh.2016.63870. Epub 2016 Nov 28. PMID: 28856278; PMCID: PMC5497429.
Copy Download .nbib Format: NLM
Dermatologic adverse events of protease inhibitor-based combination therapy in patients with chronic hepatitis C.

Journal of dermatological case reports

Kłujszo E, Parcheta P, Zarębska-Michaluk D, Ochwanowska E, Witkowska A, Rakowska A, Rudnicka L, Kryczka W.
PMID: 25621089
J Dermatol Case Rep. 2014 Dec 31;8(4):95-102. doi: 10.3315/jdcr.2014.1183. eCollection 2014 Dec 31.

BACKGROUND: Combination therapy with pegylated interferon, ribavirin and a first-generation NS3/4A protease inhibitor, telaprevir or boceprevir, is the new strategy for treatment of genotype 1 chronic hepatitis C virus infection. This combination improves therapeutic efficacy but it also increases...

Cite
Kłujszo E, Parcheta P, Zarębska-Michaluk D, et al. Dermatologic adverse events of protease inhibitor-based combination therapy in patients with chronic hepatitis C. J Dermatol Case Rep. 2014;8(4):95-102doi: 10.3315/jdcr.2014.1183.
Kłujszo, E., Parcheta, P., Zarębska-Michaluk, D., Ochwanowska, E., Witkowska, A., Rakowska, A., Rudnicka, L., & Kryczka, W. (2014). Dermatologic adverse events of protease inhibitor-based combination therapy in patients with chronic hepatitis C. Journal of dermatological case reports, 8(4), 95-102. https://doi.org/10.3315/jdcr.2014.1183
Kłujszo, Elżbieta, et al. "Dermatologic adverse events of protease inhibitor-based combination therapy in patients with chronic hepatitis C." Journal of dermatological case reports vol. 8,4 (2014): 95-102. doi: https://doi.org/10.3315/jdcr.2014.1183
Kłujszo E, Parcheta P, Zarębska-Michaluk D, Ochwanowska E, Witkowska A, Rakowska A, Rudnicka L, Kryczka W. Dermatologic adverse events of protease inhibitor-based combination therapy in patients with chronic hepatitis C. J Dermatol Case Rep. 2014 Dec 31;8(4):95-102. doi: 10.3315/jdcr.2014.1183. eCollection 2014 Dec 31. PMID: 25621089; PMCID: PMC4299703.
Copy Download .nbib Format: NLM
Distributions of fluorescence decay times for synthetic melittin in water-methanol mixtures and complexed with calmodulin, troponin C, and phospholipids.

Journal of fluorescence

Lakowicz JR, Gryczynski I, Wiczk W, Johnson ML.
PMID: 24233379
J Fluoresc. 1994 Jun;4(2):169-77. doi: 10.1007/BF01881885.

Frequency-domain measurements of the intensity decays of melittin were used to recover the distribution of decay times displayed by its single tryptophan residue. Melittin was examined in the monomeric random coil state (water), in the monomeric α-helical state (water-methanol),...

Cite
Lakowicz JR, Gryczynski I, Wiczk W, et al. Distributions of fluorescence decay times for synthetic melittin in water-methanol mixtures and complexed with calmodulin, troponin C, and phospholipids. J Fluoresc. 1994;4(2):169-77doi: 10.1007/BF01881885.
Lakowicz, J. R., Gryczynski, I., Wiczk, W., & Johnson, M. L. (1994). Distributions of fluorescence decay times for synthetic melittin in water-methanol mixtures and complexed with calmodulin, troponin C, and phospholipids. Journal of fluorescence, 4(2), 169-77. https://doi.org/10.1007/BF01881885
Lakowicz, J R, et al. "Distributions of fluorescence decay times for synthetic melittin in water-methanol mixtures and complexed with calmodulin, troponin C, and phospholipids." Journal of fluorescence vol. 4,2 (1994): 169-77. doi: https://doi.org/10.1007/BF01881885
Lakowicz JR, Gryczynski I, Wiczk W, Johnson ML. Distributions of fluorescence decay times for synthetic melittin in water-methanol mixtures and complexed with calmodulin, troponin C, and phospholipids. J Fluoresc. 1994 Jun;4(2):169-77. doi: 10.1007/BF01881885. PMID: 24233379.
Copy Download .nbib Format: NLM
Metabolic engineering of yeasts by heterologous enzyme production for degradation of cellulose and hemicellulose from biomass: a perspective.

Frontiers in microbiology

Kricka W, Fitzpatrick J, Bond U.
PMID: 24795706
Front Microbiol. 2014 Apr 22;5:174. doi: 10.3389/fmicb.2014.00174. eCollection 2014.

This review focuses on current approaches to metabolic engineering of ethanologenic yeast species for the production of bioethanol from complex lignocellulose biomass sources. The experimental strategies for the degradation of the cellulose and xylose-components of lignocellulose are reviewed. Limitations...

Cite
Kricka W, Fitzpatrick J, Bond U. Metabolic engineering of yeasts by heterologous enzyme production for degradation of cellulose and hemicellulose from biomass: a perspective. Front Microbiol. 2014;5:174doi: 10.3389/fmicb.2014.00174.
Kricka, W., Fitzpatrick, J., & Bond, U. (2014). Metabolic engineering of yeasts by heterologous enzyme production for degradation of cellulose and hemicellulose from biomass: a perspective. Frontiers in microbiology, 5174. https://doi.org/10.3389/fmicb.2014.00174
Kricka, William, et al. "Metabolic engineering of yeasts by heterologous enzyme production for degradation of cellulose and hemicellulose from biomass: a perspective." Frontiers in microbiology vol. 5 (2014): 174. doi: https://doi.org/10.3389/fmicb.2014.00174
Kricka W, Fitzpatrick J, Bond U. Metabolic engineering of yeasts by heterologous enzyme production for degradation of cellulose and hemicellulose from biomass: a perspective. Front Microbiol. 2014 Apr 22;5:174. doi: 10.3389/fmicb.2014.00174. eCollection 2014. PMID: 24795706; PMCID: PMC4001029.
Copy Download .nbib Format: NLM
4-(9-Anthryl)-2-methylbutyn-2-ol.

Acta crystallographica. Section E, Structure reports online

Bylińska I, Sikorski A, Wiczk W.
PMID: 21201508
Acta Crystallogr Sect E Struct Rep Online. 2008 Jan 23;64:o484-5. doi: 10.1107/S1600536808001542.

There are two mol-ecules in the asymmetric unit of the title compound, C(19)H(16)O. Neighbouring mol-ecules are linked through O-H⋯O hydrogen bonds into an R(4) (4)(8) ring motif. There are also C-H⋯π hydrogen and π-π inter-actions. The mol-ecules are either...

Cite
Bylińska I, Sikorski A, Wiczk W. 4-(9-Anthryl)-2-methylbutyn-2-ol. Acta Crystallogr Sect E Struct Rep Online. 2008;64:o484-5doi: 10.1107/S1600536808001542.
Bylińska, I., Sikorski, A., & Wiczk, W. (2008). 4-(9-Anthryl)-2-methylbutyn-2-ol. Acta crystallographica. Section E, Structure reports online, 64o484-5. https://doi.org/10.1107/S1600536808001542
Bylińska, Irena, et al. "4-(9-Anthryl)-2-methylbutyn-2-ol." Acta crystallographica. Section E, Structure reports online vol. 64 (2008): o484-5. doi: https://doi.org/10.1107/S1600536808001542
Bylińska I, Sikorski A, Wiczk W. 4-(9-Anthryl)-2-methylbutyn-2-ol. Acta Crystallogr Sect E Struct Rep Online. 2008 Jan 23;64:o484-5. doi: 10.1107/S1600536808001542. PMID: 21201508; PMCID: PMC2960210.
Copy Download .nbib Format: NLM
End-to-End Diffusion and Distance Distributions of Flexible Donor-Acceptor Systems Observed by Intramolecular Energy Transfer and Frequency-Domain Fluorometry; Enhanced Resolution by Global Analysis of Externally Quenched and Nonquenched Samples.

The Journal of physical chemistry

Lakowicz JR, Kuśba J, Gryczynski I, Wiczk W, Szmacinski H, Johnson ML.
PMID: 31341335
J Phys Chem. 1991 Nov 01;95(24):9654-9660. doi: 10.1021/j100177a012.

We used time-dependent fluorescence energy transfer of externally quenched and nonquenched samples, and global analysis of the data, to recover the end-to-end distance distributions and diffusion coefficients of flexible fluorescent molecules in low-viscosity solution. The fluorescence decays of tryptamine...

Cite
Lakowicz JR, Kuśba J, Gryczynski I, et al. End-to-End Diffusion and Distance Distributions of Flexible Donor-Acceptor Systems Observed by Intramolecular Energy Transfer and Frequency-Domain Fluorometry; Enhanced Resolution by Global Analysis of Externally Quenched and Nonquenched Samples. J Phys Chem. 1991;95(24):9654-9660doi: 10.1021/j100177a012.
Lakowicz, J. R., Kuśba, J., Gryczynski, I., Wiczk, W., Szmacinski, H., & Johnson, M. L. (1991). End-to-End Diffusion and Distance Distributions of Flexible Donor-Acceptor Systems Observed by Intramolecular Energy Transfer and Frequency-Domain Fluorometry; Enhanced Resolution by Global Analysis of Externally Quenched and Nonquenched Samples. The Journal of physical chemistry, 95(24), 9654-9660. https://doi.org/10.1021/j100177a012
Lakowicz, Joseph R, et al. "End-to-End Diffusion and Distance Distributions of Flexible Donor-Acceptor Systems Observed by Intramolecular Energy Transfer and Frequency-Domain Fluorometry; Enhanced Resolution by Global Analysis of Externally Quenched and Nonquenched Samples." The Journal of physical chemistry vol. 95,24 (1991): 9654-9660. doi: https://doi.org/10.1021/j100177a012
Lakowicz JR, Kuśba J, Gryczynski I, Wiczk W, Szmacinski H, Johnson ML. End-to-End Diffusion and Distance Distributions of Flexible Donor-Acceptor Systems Observed by Intramolecular Energy Transfer and Frequency-Domain Fluorometry; Enhanced Resolution by Global Analysis of Externally Quenched and Nonquenched Samples. J Phys Chem. 1991 Nov 01;95(24):9654-9660. doi: 10.1021/j100177a012. PMID: 31341335; PMCID: PMC6650637.
Copy Download .nbib Format: NLM
Ten years of anti-HPV vaccinations: what do we know?.

Przeglad menopauzalny = Menopause review

Jach R, Basta A, Kotarski J, Markowska J, Paszkowski T, Dębski R, Rokita W, Kędzia W, Kiszka K.
PMID: 27980529
Prz Menopauzalny. 2016 Nov;15(3):170-175. doi: 10.5114/pm.2016.63497. Epub 2016 Nov 15.

Human papillomavirus (HPV) is one of the most important carcinogens in humans. Vaccines against HPV are now considered the first anti-cancer vaccinations. Since 2007, in many developed countries, there have been recommendations present for preventive vaccines against HPV. At...

Cite
Jach R, Basta A, Kotarski J, et al. Ten years of anti-HPV vaccinations: what do we know?. Prz Menopauzalny. 2016;15(3):170-175doi: 10.5114/pm.2016.63497.
Jach, R., Basta, A., Kotarski, J., Markowska, J., Paszkowski, T., Dębski, R., Rokita, W., Kędzia, W., & Kiszka, K. (2016). Ten years of anti-HPV vaccinations: what do we know?. Przeglad menopauzalny = Menopause review, 15(3), 170-175. https://doi.org/10.5114/pm.2016.63497
Jach, Robert, et al. "Ten years of anti-HPV vaccinations: what do we know?." Przeglad menopauzalny = Menopause review vol. 15,3 (2016): 170-175. doi: https://doi.org/10.5114/pm.2016.63497
Jach R, Basta A, Kotarski J, Markowska J, Paszkowski T, Dębski R, Rokita W, Kędzia W, Kiszka K. Ten years of anti-HPV vaccinations: what do we know?. Prz Menopauzalny. 2016 Nov;15(3):170-175. doi: 10.5114/pm.2016.63497. Epub 2016 Nov 15. PMID: 27980529; PMCID: PMC5137481.
Copy Download .nbib Format: NLM
Predictors of sustained virological response in patients with hepatitis C virus genotype 3 infection.

Clinical and experimental hepatology

Zarębska-Michaluk D, Lebensztejn D, Chrapek M, Paluch K, Stępień P, Kryczka W.
PMID: 28856274
Clin Exp Hepatol. 2016 Sep;2(3):117-124. doi: 10.5114/ceh.2016.62526. Epub 2016 Sep 26.

AIM OF THE STUDY: To assess predictors of sustained virological response (SVR) in patients with chronic hepatitis C virus (HCV) genotype 3 treated with standard therapy.MATERIAL AND METHODS: We retrospectively investigated data of 116 consecutive treatment-naïve patients chronically infected...

Cite
Zarębska-Michaluk D, Lebensztejn D, Chrapek M, et al. Predictors of sustained virological response in patients with hepatitis C virus genotype 3 infection. Clin Exp Hepatol. 2016;2(3):117-124doi: 10.5114/ceh.2016.62526.
Zarębska-Michaluk, D., Lebensztejn, D., Chrapek, M., Paluch, K., Stępień, P., & Kryczka, W. (2016). Predictors of sustained virological response in patients with hepatitis C virus genotype 3 infection. Clinical and experimental hepatology, 2(3), 117-124. https://doi.org/10.5114/ceh.2016.62526
Zarębska-Michaluk, Dorota, et al. "Predictors of sustained virological response in patients with hepatitis C virus genotype 3 infection." Clinical and experimental hepatology vol. 2,3 (2016): 117-124. doi: https://doi.org/10.5114/ceh.2016.62526
Zarębska-Michaluk D, Lebensztejn D, Chrapek M, Paluch K, Stępień P, Kryczka W. Predictors of sustained virological response in patients with hepatitis C virus genotype 3 infection. Clin Exp Hepatol. 2016 Sep;2(3):117-124. doi: 10.5114/ceh.2016.62526. Epub 2016 Sep 26. PMID: 28856274; PMCID: PMC5497420.
Copy Download .nbib Format: NLM
Analysis of Let-7 Family miRNA in Plasma as Potential Predictive Biomarkers of Diagnosis for Papillary Thyroid Cancer.

Diagnostics (Basel, Switzerland)

Perdas E, Stawski R, Kaczka K, Zubrzycka M.
PMID: 32121086
Diagnostics (Basel). 2020 Feb 28;10(3). doi: 10.3390/diagnostics10030130.

The most common histological type of thyroid cancer is papillary thyroid carcinoma (PTC). Radical resection of the thyroid gland is currently the recommended method of treatment. Almost 75% of thyroidectomies performed just for diagnostic purposes are benign. Thus, the...

Cite
Perdas E, Stawski R, Kaczka K, et al. Analysis of Let-7 Family miRNA in Plasma as Potential Predictive Biomarkers of Diagnosis for Papillary Thyroid Cancer. Diagnostics (Basel). 2020;10(3)doi: 10.3390/diagnostics10030130.
Perdas, E., Stawski, R., Kaczka, K., & Zubrzycka, M. (2020). Analysis of Let-7 Family miRNA in Plasma as Potential Predictive Biomarkers of Diagnosis for Papillary Thyroid Cancer. Diagnostics (Basel, Switzerland), 10(3), . https://doi.org/10.3390/diagnostics10030130
Perdas, Ewelina, et al. "Analysis of Let-7 Family miRNA in Plasma as Potential Predictive Biomarkers of Diagnosis for Papillary Thyroid Cancer." Diagnostics (Basel, Switzerland) vol. 10,3 (2020). doi: https://doi.org/10.3390/diagnostics10030130
Perdas E, Stawski R, Kaczka K, Zubrzycka M. Analysis of Let-7 Family miRNA in Plasma as Potential Predictive Biomarkers of Diagnosis for Papillary Thyroid Cancer. Diagnostics (Basel). 2020 Feb 28;10(3). doi: 10.3390/diagnostics10030130. PMID: 32121086; PMCID: PMC7151036.
Copy Download .nbib Format: NLM
Total Polyphenol Content and Antioxidant Capacity of Rosehips of Some .

Medicines (Basel, Switzerland)

Koczka N, Stefanovits-Bányai É, Ombódi A.
PMID: 30081545
Medicines (Basel). 2018 Aug 04;5(3). doi: 10.3390/medicines5030084.

No abstract available.

Cite
Koczka N, Stefanovits-Bányai É, Ombódi A. Total Polyphenol Content and Antioxidant Capacity of Rosehips of Some . Medicines (Basel). 2018;5(3)doi: 10.3390/medicines5030084.
Koczka, N., Stefanovits-Bányai, �. �., & Ombódi, A. (2018). Total Polyphenol Content and Antioxidant Capacity of Rosehips of Some . Medicines (Basel, Switzerland), 5(3), . https://doi.org/10.3390/medicines5030084
Koczka, Noémi, et al. "Total Polyphenol Content and Antioxidant Capacity of Rosehips of Some ." Medicines (Basel, Switzerland) vol. 5,3 (2018). doi: https://doi.org/10.3390/medicines5030084
Koczka N, Stefanovits-Bányai É, Ombódi A. Total Polyphenol Content and Antioxidant Capacity of Rosehips of Some . Medicines (Basel). 2018 Aug 04;5(3). doi: 10.3390/medicines5030084. PMID: 30081545; PMCID: PMC6165473.
Copy Download .nbib Format: NLM
Regional Gas Transport During Conventional and Oscillatory Ventilation Assessed by Xenon-Enhanced Computed Tomography.

Annals of biomedical engineering

Herrmann J, Gerard SE, Reinhardt JM, Hoffman EA, Kaczka DW.
PMID: 33948747
Ann Biomed Eng. 2021 Sep;49(9):2377-2388. doi: 10.1007/s10439-021-02767-2. Epub 2021 May 04.

Enhanced intrapulmonary gas transport enables oscillatory ventilation modalities to support gas exchange using extremely low tidal volumes at high frequencies. However, it is unknown whether gas transport rates can be improved by combining multiple frequencies of oscillation simultaneously. The...

Cite
Herrmann J, Gerard SE, Reinhardt JM, et al. Regional Gas Transport During Conventional and Oscillatory Ventilation Assessed by Xenon-Enhanced Computed Tomography. Ann Biomed Eng. 2021;49(9):2377-2388doi: 10.1007/s10439-021-02767-2.
Herrmann, J., Gerard, S. E., Reinhardt, J. M., Hoffman, E. A., & Kaczka, D. W. (2021). Regional Gas Transport During Conventional and Oscillatory Ventilation Assessed by Xenon-Enhanced Computed Tomography. Annals of biomedical engineering, 49(9), 2377-2388. https://doi.org/10.1007/s10439-021-02767-2
Herrmann, Jacob, et al. "Regional Gas Transport During Conventional and Oscillatory Ventilation Assessed by Xenon-Enhanced Computed Tomography." Annals of biomedical engineering vol. 49,9 (2021): 2377-2388. doi: https://doi.org/10.1007/s10439-021-02767-2
Herrmann J, Gerard SE, Reinhardt JM, Hoffman EA, Kaczka DW. Regional Gas Transport During Conventional and Oscillatory Ventilation Assessed by Xenon-Enhanced Computed Tomography. Ann Biomed Eng. 2021 Sep;49(9):2377-2388. doi: 10.1007/s10439-021-02767-2. Epub 2021 May 04. PMID: 33948747.
Copy Download .nbib Format: NLM
Modelling of SMA Vibration Systems in an AVA Example.

Materials (Basel, Switzerland)

Rączka W, Konieczny J, Sibielak M.
PMID: 34640302
Materials (Basel). 2021 Oct 08;14(19). doi: 10.3390/ma14195905.

Vibration suppression, as well as its generation, is a common subject of scientific investigations. More and more often, but still rarely, shape memory alloys (SMAs) are used in vibrating systems, despite the fact that SMA springs have many advantages....

Cite
Rączka W, Konieczny J, Sibielak M. Modelling of SMA Vibration Systems in an AVA Example. Materials (Basel). 2021;14(19)doi: 10.3390/ma14195905.
Rączka, W., Konieczny, J., & Sibielak, M. (2021). Modelling of SMA Vibration Systems in an AVA Example. Materials (Basel, Switzerland), 14(19), . https://doi.org/10.3390/ma14195905
Rączka, Waldemar, et al. "Modelling of SMA Vibration Systems in an AVA Example." Materials (Basel, Switzerland) vol. 14,19 (2021). doi: https://doi.org/10.3390/ma14195905
Rączka W, Konieczny J, Sibielak M. Modelling of SMA Vibration Systems in an AVA Example. Materials (Basel). 2021 Oct 08;14(19). doi: 10.3390/ma14195905. PMID: 34640302; PMCID: PMC8510338.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 91 entries